American Vanguard (NYSE:AVD)‘s stock had its “buy” rating restated by analysts at Roth Capital in a research report issued to clients and investors on Thursday.

Separately, Zacks Investment Research lowered American Vanguard from a “hold” rating to a “sell” rating in a report on Thursday, February 8th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company’s stock. American Vanguard has a consensus rating of “Hold” and an average price target of $25.33.

How to Become a New Pot Stock Millionaire

AVD stock traded up $0.10 during trading hours on Thursday, hitting $23.05. The stock had a trading volume of 301,226 shares, compared to its average volume of 117,765. The firm has a market capitalization of $686.77, a price-to-earnings ratio of 33.41, a P/E/G ratio of 1.79 and a beta of 1.23. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.20 and a current ratio of 2.02. American Vanguard has a 1-year low of $14.90 and a 1-year high of $24.00.

American Vanguard (NYSE:AVD) last released its earnings results on Monday, March 12th. The basic materials company reported $0.17 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.17. The business had revenue of $116.50 million for the quarter, compared to analyst estimates of $110.06 million. American Vanguard had a return on equity of 5.74% and a net margin of 5.70%. The company’s revenue for the quarter was up 33.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.13 earnings per share. analysts expect that American Vanguard will post 0.86 earnings per share for the current fiscal year.

Several large investors have recently added to or reduced their stakes in the company. Macquarie Group Ltd. purchased a new stake in shares of American Vanguard in the third quarter valued at approximately $141,000. Victory Capital Management Inc. purchased a new stake in shares of American Vanguard in the third quarter valued at approximately $153,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of American Vanguard in the third quarter valued at approximately $221,000. Citadel Advisors LLC purchased a new stake in shares of American Vanguard in the third quarter valued at approximately $227,000. Finally, MetLife Investment Advisors LLC purchased a new stake in shares of American Vanguard in the fourth quarter valued at approximately $293,000. 76.80% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “American Vanguard (AVD) Given “Buy” Rating at Roth Capital” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/american-vanguard-avd-given-buy-rating-at-roth-capital/1943834.html.

About American Vanguard

American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V.

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.